MDGL icon

Madrigal Pharmaceuticals
MDGL

Upgrade to unlock
Buy
Hold
Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$630
27% upside
High target

8 analyst ratings

positive
1  neutral
13%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
Yasmeen Rahimi
50% 1-yr MDGL win rate
19 Dec ‘25 27 days ago
B. Riley Securities
B. Riley Securities
William Woods
0% 1-yr MDGL win rate
11 Dec ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Andrew Fein
67% 1-yr MDGL win rate
21 Nov ‘25 1 month ago
Oppenheimer
Oppenheimer
Jay Olson
50% 1-yr MDGL win rate
20 Nov ‘25 1 month ago
Truist Securities
Truist Securities
Srikripa Devarakonda
50% 1-yr MDGL win rate
19 Nov ‘25 1 month ago
Canaccord Genuity
Canaccord Genuity
Edward Nash
75% 1-yr MDGL win rate
13 Nov ‘25 2 months ago
Cantor Fitzgerald
Cantor Fitzgerald
Prakhar Agrawal
100% 1-yr MDGL win rate
5 Nov ‘25 2 months ago
Citizens
Citizens
Jonathan Wolleben
100% 1-yr MDGL win rate
5 Nov ‘25 2 months ago
BofA Securities
BofA Securities
Alexandria Hammond
3 Nov ‘25 2 months ago